Viewing nowCombinationLevossartan 2.5/160 Milligrams
Valsartan 160mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.

MFDS item code 201308539 · Approved 2013.07.30 · Insurance code 650204070
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension who have difficulty controlling blood pressure with monotherapy using S-Amlodipine (Amlodipine) or Valsartan. It primarily helps to stably lower blood pressure, thereby reducing the risk of cardiovascular diseases. It effectively improves blood pressure as an adjunctive treatment when blood pressure is not adequately controlled.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components ( S-amlodipine (amlodipine) or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ 2.5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy using S-amlodipine 2.5 mg (amlodipine 5 mg) or valsartan 80 mg. ㆍ 2.5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using S-amlodipine 2.5 mg (amlodipine 5 mg) or valsartan 160 mg. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using S-amlodipine 5 mg (amlodipine 10 mg) or valsartan 160 mg, or with 2.5/160 mg. Patients taking valsartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm or even death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used by those allergic to any ingredients in this medication or similar medications, pregnant or breastfeeding women, or patients with severe renal or hepatic dysfunction. Before taking this medication, if there is a deficiency of sodium or fluid in the body, these should be replenished first, and blood pressure and renal function should be carefully monitored. Additionally, patients with hyperkalemia or renal vascular problems should have potassium levels and renal function tested frequently while taking this medication, and should discontinue use immediately if symptoms of angioedema occur. Patients with heart conditions, such as those recovering from heart failure or myocardial infarction, or patients with aortic stenosis should exercise caution while taking this medication and should have regular tests for blood pressure and renal function. This medication may cause side effects such as headache, dizziness, edema, hypotension, cough, abdominal pain, rash, etc., and if symptoms are severe or persist, a consultation with a doctor is recommended. Care should also be taken while driving or operating machinery as dizziness or fatigue may occur. This medication may interact with other antihypertensive medications, potassium supplements, diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), so if you are taking other medications, be sure to inform your healthcare provider. Pregnant or planning to become pregnant women should not use this medication, and breastfeeding women are also advised to avoid it. This medication is not recommended for children under 18 years of age, as its safety and efficacy have not been established in this population. In cases of overdose, dizziness and severe hypotension can occur, so the dosage should be strictly adhered to, and if any abnormal symptoms arise, one should visit a medical institution immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from exposure to air and moisture, ideally at temperatures between 1°C and 30°C. Storing it this way can help maintain the medication's effectiveness for a long time.
Dark yellow, elongated film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationValsartan 80mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
AhnGuk Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Ahn-Gook New Pharm Co., Ltd.
CombinationValsartan 80mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Anguk New Pharm Co., Ltd.
CombinationValsartan 160mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
AhnGuk New Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.